Main competitors
Dividend Yield (N) Dividend Yield (N+1) P/E (N) Price to Book (N) EV / Sales (N) EV / EBITDA (N) EV / EBIT (N) Capi.($)
- - - - - - - 1.83B
2.66%2.73%64.97x6.09x5.25x19.51x26.42x 315B
1.69%1.76%23.37x1.96x3.21x11.46x18.91x 68.62B
2.6%2.77%17.13x1.48x2.18x7.47x8.94x 8.52B
-.--%-.--%21.18x5.63x6x16.95x17.72x 4.2B
0.79%0.79%39.31x2.34x2.22x27.39x41.35x 3.56B
-.--%-.--%108.34x - - - - 2.8B
4.05%3.5%17.45x0.76x1.37x24.54x42.01x 1.07B
-.--%-.--%-7.3x12.03x200.08x-6.48x-5.06x 949M
Average 1.47% 1.44% 35.56x 4.33x 31.47x 14.41x 21.47x 45.2B
Weighted average by Cap. 2.43% 2.5% 56.24x 5.25x 5.27x 17.88x 24.78x
Specialty & Advanced Pharmaceuticals